Smith & Nephew SNATS Current Ratio 2010-2024 | SNN
Current and historical current ratio for Smith & Nephew SNATS (SNN) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Smith & Nephew SNATS current ratio for the three months ending December 31, 2024 was 0.00.
| Smith & Nephew SNATS Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-12-31 | $4.42B | $1.53B | 2.89 |
| 2024-06-30 | $4.46B | $1.78B | 2.51 |
| 2023-12-31 | $4.03B | $2.27B | 1.78 |
| 2023-06-30 | $3.88B | $1.77B | 2.20 |
| 2022-12-31 | $3.86B | $1.72B | 2.25 |
| 2022-06-30 | $3.76B | $2.12B | 1.78 |
| 2021-12-31 | $4.42B | $2.13B | 2.08 |
| 2021-06-30 | $4.44B | $2.12B | 2.10 |
| 2020-12-31 | $4.66B | $1.69B | 2.76 |
| 2020-06-30 | $3.30B | $1.52B | 2.18 |
| 2019-12-31 | $3.22B | $1.56B | 2.06 |
| 2019-06-30 | $2.95B | $1.47B | 2.00 |
| 2018-12-31 | $3.08B | $1.47B | 2.10 |
| 2018-06-30 | $2.66B | $1.25B | 2.13 |
| 2017-12-31 | $2.73B | $1.35B | 2.03 |
| 2017-06-30 | $2.58B | $1.19B | 2.18 |
| 2016-12-31 | $2.53B | $1.35B | 1.88 |
| 2015-12-31 | $2.48B | $1.34B | 1.84 |
| 2015-06-30 | $2.43B | $1.23B | 1.99 |
| 2014-12-31 | $2.44B | $1.16B | 2.10 |
| 2014-09-30 | $2.53B | $1.23B | 2.06 |
| 2014-06-30 | $2.53B | $1.15B | 2.21 |
| 2014-03-31 | $2.39B | $1.06B | 2.25 |
| 2013-12-31 | $2.26B | $1.07B | 2.10 |
| 2013-09-30 | $2.17B | $1.03B | 2.11 |
| 2013-06-30 | $2.08B | $0.89B | 2.34 |
| 2013-03-31 | $2.07B | $0.92B | 2.26 |
| 2012-12-31 | $2.14B | $0.93B | 2.31 |
| 2012-09-30 | $2.29B | $0.91B | 2.52 |
| 2012-06-30 | $2.09B | $0.80B | 2.62 |
| 2012-03-31 | $2.32B | $1.03B | 2.26 |
| 2011-12-31 | $2.21B | $1.14B | 1.94 |
| 2011-09-30 | $2.22B | $1.29B | 1.73 |
| 2011-06-30 | $2.24B | $1.35B | 1.66 |
| 2011-03-31 | $2.21B | $0.88B | 2.51 |
| 2010-12-31 | $2.15B | $0.91B | 2.36 |
| 2010-09-30 | $2.35B | $0.86B | 2.72 |
| 2010-06-30 | $2.15B | $0.78B | 2.75 |
| 2010-03-31 | $2.09B | $0.88B | 2.38 |
| 2009-12-31 | $2.09B | $0.86B | 2.42 |
| 2009-09-30 | $2.15B | $0.91B | 2.37 |
| 2009-06-30 | $2.09B | $0.88B | 2.38 |
| 2009-03-31 | $2.00B | $1.00B | 2.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.829B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.709B | 27.40 |
| Boston Scientific (BSX) | United States | $152.828B | 36.44 |
| Stryker (SYK) | United States | $144.352B | 29.38 |
| EssilorLuxottica (ESLOY) | France | $136.813B | 0.00 |
| Medtronic (MDT) | Ireland | $119.054B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.435B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.853B | 24.46 |
| ResMed (RMD) | United States | $41.628B | 29.73 |
| GE HealthCare Technologies (GEHC) | United States | $32.872B | 15.45 |
| Agilent Technologies (A) | United States | $32.560B | 21.23 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $25.845B | 17.10 |
| Insulet (PODD) | United States | $21.612B | 72.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.663B | 12.52 |
| Baxter (BAX) | United States | $12.168B | 9.40 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.150B | 26.26 |
| Lantheus Holdings (LNTH) | United States | $3.889B | 10.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.364B | 23.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 14.32 |
| Perrigo (PRGO) | Ireland | $3.102B | 7.75 |
| ICU Medical (ICUI) | United States | $2.786B | 18.97 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.089B | 44.80 |
| AtriCure (ATRC) | United States | $1.755B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.624B | 10.22 |
| Green Thumb Industries (GTBIF) | United States | $1.509B | 64.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.368B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.240B | 17.67 |
| Phibro Animal Health (PAHC) | United States | $1.139B | 14.56 |
| Acuren (TIC) | United States | $1.138B | 0.00 |
| Neogen (NEOG) | United States | $1.103B | 17.52 |
| BioLife Solutions (BLFS) | United States | $1.086B | 2268.00 |
| InMode (INMD) | Israel | $0.892B | 8.25 |
| Valneva SE (VALN) | France | $0.775B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.746B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.714B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.560B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| ZimVie (ZIMV) | United States | $0.530B | 20.45 |
| Surmodics (SRDX) | United States | $0.506B | 0.00 |
| CeriBell (CBLL) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.414B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.393B | 13.54 |
| Evolus (EOLS) | United States | $0.382B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.347B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.341B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.88 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.232B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.80 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.214B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Exagen (XGN) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.06 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.170B | 0.00 |
| Biote (BTMD) | United States | $0.158B | 4.72 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 32.50 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.11 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |